Include more Govt sites: CDSCO panel tells Glenmark on asthma drug combination
Citing that more government sites shall be included in the study with geographical distribution, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Glenmark Pharmaceutical to revise Phase III clinical trial protocol of Glycopyrrolate plus Fluticasone Furoate plus Vilanterol Trifenatate Powder for inhalation in capsule, indicated for the treatment of uncontrolled asthma.
For more details, check out the link given below:
Include More Govt Sites: CDSCO Panel Tells Glenmark On Asthma Drug Combination
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.